Fever and Vaccines: Good or Bad?

Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

Linda Stein Gold, MD;Sydney Jennings

March 9th 2025

Amyloid and Tau Biomarkers of Alzheimer Disease Found in Individuals with Other Dementias

“I think it’s important to have a lot of tools in our toolbox, and [tapinarof cream 1%] is one that gives us great flexibility," said Linda Stein Gold, MD.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Biomarkers in a pattern characteristic of Alzheimer pathology were identified in unspecified dementia, Parkinson dementia, and frontotemporal dementia.

Keith A. Reynolds

October 1st 2024

Switching Anti-CGRP Monoclonal Antibody Therapy in Nonresponders with Migraine May Reduce Monthly Headache Days

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

For Patients with Migraine who do Not Initially Respond to CGRP Inhibitor Therapy, Switching mAbs May Provide Relief / image credit courtesy of Fundación Jiménez Díaz University Hospital

Dupilumab Effective, Safe for Severe Pediatric Atopic Dermatitis: Daily Dose

Subgroup analyses found no significant difference in efficacy based on change in therapeutic action (ie, CGRP vs its receptor), doses, or intertreatment interval.

Sydney Jennings

Your daily dose of the clinical news you may have missed.

Related Content

DKA Knowledge Challenge!

Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

Linda Stein Gold, MD;Sydney Jennings

March 9th 2025

Amyloid and Tau Biomarkers of Alzheimer Disease Found in Individuals with Other Dementias

“I think it’s important to have a lot of tools in our toolbox, and [tapinarof cream 1%] is one that gives us great flexibility," said Linda Stein Gold, MD.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Biomarkers in a pattern characteristic of Alzheimer pathology were identified in unspecified dementia, Parkinson dementia, and frontotemporal dementia.

Keith A. Reynolds

October 1st 2024

Switching Anti-CGRP Monoclonal Antibody Therapy in Nonresponders with Migraine May Reduce Monthly Headache Days

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Dupilumab Effective, Safe for Severe Pediatric Atopic Dermatitis: Daily Dose

Subgroup analyses found no significant difference in efficacy based on change in therapeutic action (ie, CGRP vs its receptor), doses, or intertreatment interval.

Sydney Jennings